NNVC financials
NanoViricides (NNVC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NNVC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | – | – | -$8.31M | -$8.22M | -0.41 |
| 2025 | – | – | -$9.59M | -$9.47M | -0.63 |
| 2024 | – | – | -$8.52M | -$8.29M | -0.70 |
| 2023 | – | – | -$8.94M | -$8.59M | -0.74 |
| 2022 | – | – | -$8.11M | -$8.11M | -0.70 |
| 2021 | – | – | -$8.74M | -$8.82M | -0.81 |